Plasma glycoproteomic biomarkers identify metastatic melanoma patients with reduced clinical benefit from immune checkpoint inhibitor therapy
血浆糖蛋白组学生物标志物可识别出从免疫检查点抑制剂治疗中获益较少的转移性黑色素瘤患者
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2023.1187332
Pickering, Chad; Aiyetan, Paul; Xu, Gege; Mitchell, Alan; Rice, Rachel; Najjar, Yana G; Markowitz, Joseph; Ebert, Lisa M; Brown, Michael P; Tapia-Rico, Gonzalo; Frederick, Dennie; Cong, Xin; Serie, Daniel; Lindpaintner, Klaus; Schwarz, Flavio; Boland, Genevieve M